Literature DB >> 24798117

Summarizing the fifteen scales of the EORTC QLQ-C30 questionnaire by five aggregate scales with two underlying dimensions: a literature review and an empirical study.

Willem A van der Kloot1, Kunihiko Kobayashi, Kazue Yamaoka, Kenichi Inoue, Hans W R Nortier, Ad A Kaptein.   

Abstract

The intercorrelations among the 15 scales of the 30-item Core version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire suggest that one may combine (1) the physical functioning and role functioning scales, (2) the emotional functioning and cognitive functioning scales, and (3) the nine symptom scales. Together with the global health/quality of life scale and the social functioning scale, five measures remain. Principal component analysis of those five measures, using data from Japanese and Dutch breast and lung cancer patients, yielded two dimensions: (1) generalized health related quality of life and (2) health-independent psychological well-being. The correlations of these dimensions with the Brief Illness Perception Questionnaire and Karnofsky performance substantiated this interpretation.

Entities:  

Keywords:  EORTC QLQ-C30; cancer; categorical principal component analysis; health-related quality of life; illness perception

Mesh:

Year:  2014        PMID: 24798117     DOI: 10.1080/07347332.2014.917139

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  2 in total

1.  Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.

Authors:  S P Somashekhar; K R Ashwin; C Amit Rauthan; Kumar C Rohit
Journal:  Pleura Peritoneum       Date:  2018-09-26

2.  Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.

Authors:  Florian Struller; Philipp Horvath; Wiebke Solass; Frank-Jürgen Weinreich; Dirk Strumberg; Marios K Kokkalis; Imma Fischer; Christoph Meisner; Alfred Königsrainer; Marc A Reymond
Journal:  Ther Adv Med Oncol       Date:  2019-05-13       Impact factor: 8.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.